| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/30/2018 | Liquidia Technologies Inc | LQDA | Conversion | Common Stock, par value $0.001 per share | 191.8k | $0.00 | $0 | See footnotes | 07/30/2018 |
| 07/30/2018 | Liquidia Technologies Inc | LQDA | Conversion | Common Stock, par value $0.001 per share | 97.3k | $0.00 | $0 | See footnotes | 07/30/2018 |
| 07/30/2018 | Liquidia Technologies Inc | LQDA | Conversion | Series C Preferred Stock, par value $0.001 per share | 1.5M | $0.00 | $0 | See footnotes | 07/30/2018 |
| 07/30/2018 | Liquidia Technologies Inc | LQDA | Conversion | Series D Preferred Stock, par value $0.001 per share | 1.6M | $0.00 | $0 | See footnotes | 07/30/2018 |
| 06/25/2018 | Kezar Life Sciences, Inc. | KZR | Conversion | Series B Preferred Stock, par value $0.001 per share | 23.9k | $0.00 | $0 | See footnotes | 06/25/2018 |
| 06/25/2018 | Kezar Life Sciences, Inc. | KZR | Conversion | Series B Preferred Stock, par value $0.001 per share | 290.9k | $0.00 | $0 | See footnotes | 06/25/2018 |
| 06/25/2018 | Kezar Life Sciences, Inc. | KZR | Conversion | Common Stock, par value $0.001 per share | 23.9k | $0.00 | $0 | See footnotes | 06/25/2018 |
| 06/25/2018 | Kezar Life Sciences, Inc. | KZR | Conversion | Common Stock, par value $0.001 per share | 290.9k | $0.00 | $0 | See footnotes | 06/25/2018 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series C Convertible Preferred Stock | 20.8k | $0.00 | $0 | By PV III CEO Fund, L.P. | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series C Convertible Preferred Stock | 334.7k | $0.00 | $0 | By A. M. Pappas Life Science Ventures III, L.P. | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series B Convertible Preferred Stock | 42k | $0.00 | $0 | By PV III CEO Fund, L.P. | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series B Convertible Preferred Stock | 675.6k | $0.00 | $0 | By A. M. Pappas Life Science Ventures III, L.P. | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series A Convertible Preferred Stock | 36k | $0.00 | $0 | By PV III CEO Fund, L.P. | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Series A Convertible Preferred Stock | 578.3k | $0.00 | $0 | By A. M. Pappas Life Science Ventures III, L.P. | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Common Stock | 17.6k | $10.00 | $175.6k | By PV III CEO Fund, L.P. | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Common Stock | 282.4k | $10.00 | $2.8M | By A. M. Pappas Life Science Ventures III, L.P. | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Common Stock | 98.8k | $0.00 | $0 | By PV III CEO Fund, L.P. | 05/11/2015 |
| 05/11/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Conversion | Common Stock | 1.6M | $0.00 | $0 | By A. M. Pappas Life Science Ventures III, L.P. | 05/11/2015 |
| 05/05/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Grant | Stock Option (Right to Buy) | 6k | $10.00 | $59.5k | | 05/05/2015 |
| 03/23/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Exercise | Stock Option (Right to Buy) | 5.5k | $0.00 | $0 | By A.M. Pappas & Associates, LLC | 05/05/2015 |
| 03/23/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Exercise | Common Stock | 5.5k | $4.07 | $22.5k | By A.M. Pappas & Associates, LLC | 05/05/2015 |
| 01/12/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Series C Convertible Preferred Stock | 20.8k | $0.00 | $0 | By PV III CEO Fund, L.P. | 05/05/2015 |
| 01/12/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Series C Convertible Preferred Stock | 334.7k | $0.00 | $0 | By A. M. Pappas Life Science Ventures III, L.P. | 05/05/2015 |
| 01/12/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Series B Convertible Preferred Stock | 33.6k | $0.00 | $0 | By PV III CEO Fund, L.P. | 05/05/2015 |
| 01/12/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Series B Convertible Preferred Stock | 540.5k | $0.00 | $0 | By A. M. Pappas Life Science Ventures III, L.P. | 05/05/2015 |
| 01/12/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Series A Convertible Preferred Stock | 28.8k | $0.00 | $0 | By PV III CEO Fund, L.P. | 05/05/2015 |
| 01/12/2015 | CoLucid Pharmaceuticals, Inc. | CLCD | Purchase | Series A Convertible Preferred Stock | 462.6k | $0.00 | $0 | By A. M. Pappas Life Science Ventures III, L.P. | 05/05/2015 |